Literature DB >> 23814152

Biomarkers in DSM-5: lost in translation.

Bernard J Carroll1.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23814152     DOI： 10.1177/0004867413491162

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN： 0004-8674            Impact factor:   5.744


× No keyword cloud information.
  5 in total

1.  Adherence to psychiatric treatments and the public image of psychiatry.

Authors:  Mario Maj
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

2.  DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences--part 1: general aspects and paradigmatic discussion of depressive disorders.

Authors:  Hans-Jürgen Möller; Borwin Bandelow; Michael Bauer; Harald Hampel; Sabine C Herpertz; Michael Soyka; Utako B Barnikol; Simone Lista; Emanuel Severus; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-14       Impact factor: 5.270

3.  The media campaign on the DSM-5: recurring comments and lessons for the future of diagnosis in psychiatric practice.

Authors:  M Maj
Journal:  Epidemiol Psychiatr Sci       Date:  2014-09-10       Impact factor: 6.892

4.  Eugen Bleuler's schizophrenia--a modern perspective.

Authors:  Anke Maatz; Paul Hoff; Jules Angst
Journal:  Dialogues Clin Neurosci       Date:  2015-03       Impact factor: 5.986

5.  Increased Serum NSE and S100B Indicate Neuronal and Glial Alterations in Subjects Under 71 Years With Mild Neurocognitive Disorder/Mild Cognitive Impairment.

Authors:  Maryna Polyakova; Karsten Mueller; Katrin Arelin; Leonie Lampe; Francisca S Rodriguez; Tobias Luck; Jürgen Kratzsch; Karl-Titus Hoffmann; Steffi Riedel-Heller; Arno Villringer; Peter Schoenknecht; Matthias L Schroeter
Journal:  Front Cell Neurosci       Date:  2022-07-14       Impact factor: 6.147
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.